As the world’s leader in clinical research of hyperpolarized MRI, UVA is ushering in a new era of diagnostic advancement for pulmonary diseases.
Tag: uva pulmonology
UVA Adult Cystic Fibrosis Clinic caught the nation’s attention for its successful and quick transition to telehealth.
Imre Noth, MD, helped secure $22 million in NIH and private funding to dramatically alter how idiopathic pulmonary fibrosis (IPF) is diagnosed and treated.
UVA pulmonologists established one of the nation's first post-COVID clinics and brings valuable insights into COVID’s longterm toll by tying clinical data to blood biomarkers.
A case study highlighting the collaborative care required to help one mother survive a complex pregnancy and delivery.
Imre Noth, MD, is an expert on interstitial lung diseases with a special emphasis on idiopathic pulmonary fibrosis. He has joined UVA as chief of the Division of Pulmonary and Critical Care Medicine.
The UVA Interstitial Lung Disease Program is one of just 40 centers in the U.S. designated as a Pulmonary Fibrosis Foundation Care Network site, which speaks to the level of expertise and quality of care provided, as well as the progress being made at UVA in advancing treatment for these complex lung disorders.